Dynamic Technology Lab Private Ltd Has $2.91 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

Dynamic Technology Lab Private Ltd lifted its holdings in Avantor, Inc. (NYSE:AVTR) by 169.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 112,388 shares of the company’s stock after acquiring an additional 70,753 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Avantor were worth $2,908,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. UniSuper Management Pty Ltd increased its stake in Avantor by 97.9% during the 1st quarter. UniSuper Management Pty Ltd now owns 9,500 shares of the company’s stock worth $243,000 after acquiring an additional 4,700 shares during the period. Quadrature Capital Ltd increased its position in shares of Avantor by 45.3% in the first quarter. Quadrature Capital Ltd now owns 18,265 shares of the company’s stock worth $467,000 after purchasing an additional 5,695 shares during the period. Mount Yale Investment Advisors LLC raised its stake in Avantor by 93.9% in the first quarter. Mount Yale Investment Advisors LLC now owns 18,722 shares of the company’s stock valued at $479,000 after purchasing an additional 9,066 shares in the last quarter. Paloma Partners Management Co bought a new stake in Avantor during the first quarter worth about $219,000. Finally, Kennedy Capital Management LLC grew its stake in Avantor by 50.9% during the first quarter. Kennedy Capital Management LLC now owns 79,483 shares of the company’s stock worth $2,032,000 after buying an additional 26,814 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. UBS Group dropped their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Stifel Nicolaus boosted their price objective on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Barclays cut their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Wells Fargo & Company decreased their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Finally, TD Cowen upped their price objective on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $27.57.

Insider Buying and Selling

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.50% of the stock is currently owned by insiders.

Avantor Trading Up 2.1 %

AVTR opened at $20.78 on Monday. The company’s 50 day moving average price is $23.89 and its two-hundred day moving average price is $23.85. The firm has a market capitalization of $14.14 billion, a price-to-earnings ratio of 45.17, a PEG ratio of 2.47 and a beta of 1.35. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.